Department of Physiology and Pharmacology, Center for the Neurobiology of Addiction Treatments (CNAT), Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1083, USA.
Psychopharmacology (Berl). 2010 May;209(4):375-82. doi: 10.1007/s00213-010-1807-x. Epub 2010 Mar 9.
Agonist medications have been proven effective in treating opioid and nicotine dependence; results from clinical studies suggest that the indirect dopamine agonist d-amphetamine may reduce cocaine abuse. In preclinical studies, chronic d-amphetamine treatment decreased ongoing cocaine self-administration.
The present study extended previous results by determining effects of chronic d-amphetamine treatment on the reinforcing strength of cocaine under conditions in which access to cocaine was suspended during d-amphetamine treatment.
Daily operant conditioning sessions consisted of morning access to food pellets delivered under a 50-response fixed-ratio schedule and evening access to cocaine (0.005-0.48 mg/kg per injection, i.v.) under a progressive-ratio schedule. After responding maintained by 0.045 mg/kg per injection cocaine stabilized, self-administration sessions were suspended and d-amphetamine (0.01-0.1 mg/kg per hr, i.v.) was administered continuously for 5 days. On the following day, d-amphetamine treatment was discontinued and daily self-administration sessions resumed.
Following termination of d-amphetamine treatment, food- and cocaine-maintained responding was decreased in a dose-related manner. Decreases in the reinforcing strength of cocaine were larger and lasted longer than effects on food reinforcement. However, cocaine self-administration was unaltered if 6 days elapsed between discontinuation of d-amphetamine treatment and the next cocaine self-administration session.
The necessity of a self-administration session in the presence of d-amphetamine suggests that the protracted decrease in cocaine self-administration may be a manifestation of behavioral tolerance. Regarding treatment of cocaine dependence, data suggest that prolonged d-amphetamine treatment may be necessary to produce a sustained reduction in the reinforcing effects of cocaine.
激动剂药物已被证明可有效治疗阿片类药物和尼古丁依赖;临床研究结果表明,间接多巴胺激动剂 d-苯丙胺可能减少可卡因滥用。在临床前研究中,慢性 d-苯丙胺治疗减少了可卡因的持续自我给药。
本研究通过确定慢性 d-苯丙胺治疗对可卡因强化作用的影响,扩展了以前的结果,即在 d-苯丙胺治疗期间暂停可卡因使用的情况下。
每日操作性条件作用会话由早晨进食丸(根据 50 次固定比例计划交付)和晚上可卡因(0.005-0.48 mg/kg 每剂,静脉内)(根据渐进比例计划)组成。当 0.045mg/kg 每剂可卡因维持的反应稳定后,自我给药会话暂停,d-苯丙胺(0.01-0.1mg/kg 每小时,静脉内)连续给药 5 天。在接下来的一天,停止 d-苯丙胺治疗,每天恢复自我给药会话。
在 d-苯丙胺治疗终止后,食物和可卡因维持的反应以剂量相关的方式减少。可卡因强化作用的降低比食物强化作用的降低更大且持续时间更长。然而,如果在停止 d-苯丙胺治疗和下一次可卡因自我给药会话之间间隔 6 天,则可卡因自我给药不会改变。
在 d-苯丙胺存在的情况下自我给药会话的必要性表明,可卡因自我给药的长期减少可能是行为耐受性的表现。关于可卡因依赖的治疗,数据表明,可能需要延长 d-苯丙胺治疗才能产生可卡因强化作用的持续减少。